Gaurav Goparaju
Stock Analyst at Berenberg
(0.21)
# 4,119
Out of 4,749 analysts
7
Total ratings
14.29%
Success rate
-13.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gaurav Goparaju
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiates: Buy | $27 | $52.37 | -48.44% | 1 | Sep 27, 2023 | |
| DNA Ginkgo Bioworks Holdings | Initiates: Buy | $240 | $13.36 | +1,696.41% | 1 | Nov 29, 2022 | |
| ME 23andMe Holding Co. | Initiates: Buy | $140 | $3.10 | +4,416.13% | 1 | Nov 29, 2022 | |
| CERT Certara | Initiates: Buy | $23 | $14.23 | +61.63% | 1 | Sep 8, 2022 | |
| ABSI Absci | Initiates: Buy | $28 | $3.71 | +654.72% | 1 | Feb 1, 2022 | |
| RLAY Relay Therapeutics | Initiates: Buy | $45 | $4.47 | +906.71% | 1 | Feb 1, 2022 | |
| SDGR Schrödinger | Initiates: Buy | $91 | $25.08 | +262.91% | 1 | Oct 13, 2021 |
Twist Bioscience
Sep 27, 2023
Initiates: Buy
Price Target: $27
Current: $52.37
Upside: -48.44%
Ginkgo Bioworks Holdings
Nov 29, 2022
Initiates: Buy
Price Target: $240
Current: $13.36
Upside: +1,696.41%
23andMe Holding Co.
Nov 29, 2022
Initiates: Buy
Price Target: $140
Current: $3.10
Upside: +4,416.13%
Certara
Sep 8, 2022
Initiates: Buy
Price Target: $23
Current: $14.23
Upside: +61.63%
Absci
Feb 1, 2022
Initiates: Buy
Price Target: $28
Current: $3.71
Upside: +654.72%
Relay Therapeutics
Feb 1, 2022
Initiates: Buy
Price Target: $45
Current: $4.47
Upside: +906.71%
Schrödinger
Oct 13, 2021
Initiates: Buy
Price Target: $91
Current: $25.08
Upside: +262.91%